Abnormal High Expression of B-Cell Activating Factor Belonging to the TNF Superfamily (BAFF) Associated With Long-Term Outcome in Kidney Transplant Recipients

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1552-1556

  Xu, H ^a   He, X ^a   Liu, Q ^a   Shi, D ^a   Chen, Y ^a   Zhu, Y ^a   Zhang, X ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CREATININE; HLA ANTIBODY; MESSENGER RNA; PANEL REACTIVE ANTIBODY;

ARTICLE; BLOOD ANALYSIS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FOLLOW UP; GRAFT RECIPIENT; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; DNA PRIMERS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-D ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; REFERENCE VALUES; RNA, MESSENGER; TREATMENT FAILURE; TREATMENT OUTCOME; UREMIA;

EID: 67249161386     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.024     Document Type: Article

References (24)

1. Mackay F., Schneider P., Rennert P., et al. BAFF and APRIL: a tutorial on B cell survival. Annu Rev Immunol 21 (2003) 231
2. Mackay F., and Browning J.L. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2 (2002) 465
3. Kalled S.L. The role of BAFF in immune function and implications for autoimmunity. Immunol Rev 204 (2005) 43
4. Mackay F., and Tangye S.G. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr Opin Pharmacol 4 (2004) 347
5. Mackay F., Sierro F., Grey S.T., et al. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun 8 (2005) 243
6. Batten M., Groom J., Cachero T.G., et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192 (2000) 1453
7. Mackay F., Woodcock S.A., Lawton P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190 (1999) 1697
8. Gross J.A., Johnston J., Mudri S., et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404 (2000) 995
9. Khare S.D., Sarosi I., Xia X.-Z., et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A 97 (2000) 3370
10. Groom J., Kalleld S.L., Culter A.H., et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 109 (2002) 59
11. Batten M., Fletcher C., Ng L.G., et al. TNF deficiency fails to protect transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J Immunol 172 (2004) 812
12. Thien M., Phan T.G., Gardam S., et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20 (2004) 785
13. Mariette X., Roux S., Zhang J., et al. The level of Blys (BAFF) correlates with the titer of autoantibodies in human Sjögren's syndrome. Ann Rheum Dis 62 (2003) 168
14. Becker-Merok A., Nikolaisen C., and Nossent H.C. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time. Lupus 15 (2006) 570
15. Petri M., Stohl W., Chatham W., et al. Association of plasma B lymphocytes stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum 58 (2008) 2453
16. Lavie F., Miceli-Richard C., Quillard J., et al. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome. J Pathol 202 (2004) 496
17. Sarantopoulos S., Stevenson K.E., Kim H.T., et al. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clin Cancer Res 13 (2007) 6107
18. Fujii H., Cuvelier G., She K., et al. Biomarkers in newly diagnosed pediatric extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood 111 (2008) 3276
19. Xu H.Y., He X.Z., Zhu Y.B., et al. Abnormally high expression of BAFF on T lymphocytes from lung cancer-associated pleural effusions and its potent anti-tumor effect. Acta Biochim Biophys Sinica 39 (2007) 964
20. Huard B., Arlettaz L., Ambrose C., et al. BAFF production by antigen-presenting cells provides T cell co-stimulation. Int Immunol 16 (2004) 467
21. Mackay F., and Leung H. The role of the BAFF/APRIL system on T cell function. Semin Immunol 18 (2006) 284
22. Avery D.T., Kalled S.L., Ellyard J.I., et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest 112 (2003) 286
23. Nardelli B., Belvedere O., Roschke V., et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97 (2001) 198
24. Schneider P., Mackay F., Steiner V., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189 (1999) 1747